Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Badger Meter Inc (BMI) vs Cassava Sciences Inc (FLNA) Price & Performance

Badger Meter IncTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Badger Meter Inc vs Cassava Sciences Inc — how do they compare? Badger Meter Inc trades at $135.56 (market cap $3.95B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Badger Meter Inc is far larger — about 82.7× Cassava Sciences Inc's market cap, and Badger Meter Inc pays a 1.17% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.

BMIFLNA
Market Cap
$3.95B$47.75M
Sector
TechnologyHealth
52-Week High
$193.09$4.64
52-Week Low
$113.41$0.87
Enterprise Value
$3.86B-$34.93M
Dividend Yield
1.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Badger Meter Inc

Badger Meter (BMI) trades at $138.86, up 1.23% today, with a bullish technical signal from moving averages and a consensus analyst price target of $155.20. Recent earnings show a Q2 2026 beat but misses in prior quarters, while financials indicate solid profitability with a 14.27% net income margin. The stock faces headwinds from multiple class-action lawsuits alleging securities fraud, as reported by Business Wire and GlobeNewsWire in early August 2026, though insider buying by a VP in late July signals confidence.

The outlook is mixed: strong fundamentals and analyst upside support growth, but legal risks and earnings volatility pose challenges. Investors may find value if legal concerns resolve, but caution is warranted due to potential sentiment pressure from ongoing litigation.

Cassava Sciences Inc

FLNA trades at $0.995, up 3.75% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of -$0.18 beating expectations of -$0.225. Financials show negative cash flows and profitability, with ROE at -55.79% and net income of -$90.97M in 2025. Analyst consensus is strongly positive with 8 buy ratings out of 12.

Despite operational losses, FLNA's consistent earnings beats and strong analyst support suggest potential upside if clinical developments progress. Key risks include sustained cash burn, lack of revenue, and dependence on successful drug trials for Tuberous Sclerosis Complex. The stock remains speculative with high volatility expected.

Returns comparison

Trailing returns across standard periods

About Badger Meter Inc

Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.

Read more on BMI

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA